111
Participants
Start Date
October 19, 2017
Primary Completion Date
April 24, 2018
Study Completion Date
April 24, 2018
Tirzepatide
Administered SC
Placebo
Administered SC
Suncoast Research Group, LLC, Miami
New Phase Research & Development, Knoxville
Aventiv Research, Columbus
Clinical Research Professionals, St Louis
Cotton O'Neil Diabetes and Endocrinology Center, Topeka
Dallas Diabetes Endocrine Center, Dallas
Consano Clinical Research, Shavano Park
Solaris Clinical Research, Meridian
National Research Institute, Los Angeles
Catalina Research Institute, LLC, Montclair
University Clinical Investigators, Inc., Tustin
Valley Research, Fresno
Chase Medical Research, LLC, Waterbury
Eli Lilly and Company
INDUSTRY